CellBion Co., Ltd. (KOSDAQ:308430)
South Korea · Delayed Price · Currency is KRW 26,850
-600 (-2.19%)
At close: Mar 19, 2026
CellBion Market Cap
CellBion has a market cap or net worth of 396.49 billion as of March 20, 2026. Its market cap has increased by 98.29% in one year.
Market Cap
396.49B
Enterprise Value
375.37B
Revenue
2.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
26,850.00
Market Cap Chart
Since October 16, 2024, CellBion's market cap has increased from 263.06B to 396.49B, an increase of 50.72%. That is a compound annual growth rate of 33.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 396.49B | 30.93% |
| Dec 30, 2025 | 302.82B | 100.48% |
| Dec 30, 2024 | 151.05B | -42.58% |
| Oct 16, 2024 | 263.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Myung In Pharmaceutical LTD. | 858.48B |
| Samyang Biopharm | 756.23B |
| ImmuneOncia Therapeutics | 645.98B |
| HEM Pharma | 502.02B |
| DAE HWA Pharmaceutical | 257.32B |
| NOVAREX | 238.80B |
| OPTUS Pharmaceutical | 210.17B |
| High Tech Pharm | 205.65B |